HUP0104126A3 - Remedies for bone metabolic errors - Google Patents
Remedies for bone metabolic errorsInfo
- Publication number
- HUP0104126A3 HUP0104126A3 HU0104126A HUP0104126A HUP0104126A3 HU P0104126 A3 HUP0104126 A3 HU P0104126A3 HU 0104126 A HU0104126 A HU 0104126A HU P0104126 A HUP0104126 A HU P0104126A HU P0104126 A3 HUP0104126 A3 HU P0104126A3
- Authority
- HU
- Hungary
- Prior art keywords
- remedies
- bone metabolic
- metabolic errors
- errors
- bone
- Prior art date
Links
- 210000000988 bone and bone Anatomy 0.000 title 1
- 230000002503 metabolic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP32287498 | 1998-10-28 | ||
| PCT/JP1999/005963 WO2000024416A1 (fr) | 1998-10-28 | 1999-10-28 | Agents therapeutiques pour deformations osseuses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0104126A2 HUP0104126A2 (hu) | 2002-03-28 |
| HUP0104126A3 true HUP0104126A3 (en) | 2004-07-28 |
Family
ID=18148585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0104126A HUP0104126A3 (en) | 1998-10-28 | 1999-10-28 | Remedies for bone metabolic errors |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6919312B2 (hu) |
| EP (1) | EP1127578A4 (hu) |
| JP (1) | JP3860415B2 (hu) |
| KR (1) | KR20010082272A (hu) |
| CN (1) | CN1183961C (hu) |
| AU (1) | AU755422B2 (hu) |
| BR (1) | BR9914834A (hu) |
| CA (1) | CA2347107A1 (hu) |
| CZ (1) | CZ20011378A3 (hu) |
| HK (1) | HK1042847A1 (hu) |
| HU (1) | HUP0104126A3 (hu) |
| IL (1) | IL142557A0 (hu) |
| MX (1) | MXPA01004225A (hu) |
| NO (1) | NO20012106L (hu) |
| NZ (1) | NZ511506A (hu) |
| PL (1) | PL347559A1 (hu) |
| RU (1) | RU2223782C2 (hu) |
| TR (1) | TR200101146T2 (hu) |
| TW (1) | TW529954B (hu) |
| WO (1) | WO2000024416A1 (hu) |
| ZA (1) | ZA200103296B (hu) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL117175A (en) | 1995-02-20 | 2005-11-20 | Sankyo Co | Osteoclastogenesis inhibitory factor protein |
| EP1127578A4 (en) | 1998-10-28 | 2004-12-15 | Sankyo Co | MEDICINE FOR BONE METABOLIC DEVIATIONS |
| US6593310B1 (en) * | 2000-11-21 | 2003-07-15 | Arthropharm Pty. Ltd. | Treatment of osteoporosis |
| ES2337716T3 (es) | 2001-04-03 | 2010-04-28 | Societe Des Produits Nestle S.A. | Osteoprotegerina en la leche. |
| EP1270015A3 (en) * | 2001-06-29 | 2004-02-25 | Sankyo Company Limited | A complex comprising OCIF and Polysaccharide |
| EP1482978A1 (en) * | 2002-03-01 | 2004-12-08 | Sankyo Company, Limited | Pharmaceutical composition comprising osteoclastogenesis inhibitory factor |
| AU2003242265A1 (en) * | 2002-06-07 | 2003-12-22 | Sankyo Company, Limited | Combined effects of therapeutic or preventive agent composition for bone breakage |
| BRPI0611535B1 (pt) | 2005-05-05 | 2021-11-30 | Sensient Flavors Inc | Método para processar células de levedura para produzir beta-glucanos e mananas |
| JPWO2008041774A1 (ja) * | 2006-10-02 | 2010-02-04 | 独立行政法人物質・材料研究機構 | 骨伝導能を有する徐放性製剤 |
| US20090028954A1 (en) * | 2006-12-22 | 2009-01-29 | Mathys Ag Bettlach | Precursor for the preparation of a pasty bone replacement material by admixture of a liquid |
| EP2509607B1 (en) * | 2009-12-09 | 2017-09-06 | Agency For Science, Technology And Research | Glycosaminoglycan mixtures |
| CN113088487B (zh) * | 2020-04-30 | 2022-12-06 | 威海见生生物技术有限公司 | 一种间充质干细胞成脂转化抑制剂 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2604135B2 (ja) * | 1986-02-28 | 1997-04-30 | ライオン株式会社 | 口腔骨疾患治療剤 |
| IL91438A (en) * | 1989-08-25 | 1995-03-30 | Bukh Meditec | Preparation for treating dental disease |
| TW318142B (hu) * | 1991-06-03 | 1997-10-21 | Mitsubishi Chemicals Co Ltd | |
| IL117175A (en) * | 1995-02-20 | 2005-11-20 | Sankyo Co | Osteoclastogenesis inhibitory factor protein |
| US6613544B1 (en) * | 1995-12-22 | 2003-09-02 | Amgen Inc. | Osteoprotegerin |
| US20030207827A1 (en) * | 1995-12-22 | 2003-11-06 | William J. Boyle | Osteoprotegerin |
| US6369027B1 (en) | 1995-12-22 | 2002-04-09 | Amgen Inc. | Osteoprotegerin |
| JPH1057071A (ja) | 1996-08-19 | 1998-03-03 | Snow Brand Milk Prod Co Ltd | 新規ｄｎａ及びそれを用いた蛋白質の製造方法 |
| RU2238949C2 (ru) | 1997-04-15 | 2004-10-27 | Санкио Компани Лимитед | Белок, специфически связывающийся с ингибирующим остеокластогенез фактором (ocif) (варианты), днк его кодирующая (варианты), днк в качестве зонда (варианты), способ получения белка (варианты), способ скрининга вещества (варианты), антитело (варианты), способ получения поликлонального антитела, гибридома (варианты), способ получения моноклонального антитела, способ измерения ocif-связывающего белка, фармацевтическая композиция (варианты) и лекарственное средство (варианты) |
| US6656508B2 (en) * | 1997-04-17 | 2003-12-02 | Amgen Inc. | Sustained-release alginate gels |
| ATE328281T1 (de) * | 1997-09-24 | 2006-06-15 | Sankyo Co | Methode zur diagnose von abnormalem knochenstoffwechsel |
| WO1999065916A1 (en) | 1998-06-15 | 1999-12-23 | Takeda Chemical Industries, Ltd. | Thienodipyridine derivatives, production and use thereof |
| EP1127578A4 (en) | 1998-10-28 | 2004-12-15 | Sankyo Co | MEDICINE FOR BONE METABOLIC DEVIATIONS |
| WO2001003719A2 (en) | 1999-07-09 | 2001-01-18 | Amgen Inc. | Combination therapy for conditions leading to bone loss |
| CA2349406C (en) * | 1999-09-03 | 2011-01-11 | Amgen Inc. | Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer |
| MXPA02006027A (es) | 1999-12-16 | 2002-12-05 | Amgen Inc | Moleculas tipo osteoprotegerina/receptor del factor de necrosis de tumor y usos de las mismas. |
| EP1270015A3 (en) * | 2001-06-29 | 2004-02-25 | Sankyo Company Limited | A complex comprising OCIF and Polysaccharide |
| EP1482978A1 (en) * | 2002-03-01 | 2004-12-08 | Sankyo Company, Limited | Pharmaceutical composition comprising osteoclastogenesis inhibitory factor |
-
1999
- 1999-10-28 EP EP99952793A patent/EP1127578A4/en not_active Withdrawn
- 1999-10-28 MX MXPA01004225A patent/MXPA01004225A/es unknown
- 1999-10-28 AU AU64877/99A patent/AU755422B2/en not_active Ceased
- 1999-10-28 JP JP2000578024A patent/JP3860415B2/ja not_active Expired - Fee Related
- 1999-10-28 TR TR2001/01146T patent/TR200101146T2/xx unknown
- 1999-10-28 CZ CZ20011378A patent/CZ20011378A3/cs unknown
- 1999-10-28 TW TW088118658A patent/TW529954B/zh not_active IP Right Cessation
- 1999-10-28 PL PL99347559A patent/PL347559A1/xx not_active Application Discontinuation
- 1999-10-28 NZ NZ511506A patent/NZ511506A/xx unknown
- 1999-10-28 WO PCT/JP1999/005963 patent/WO2000024416A1/ja not_active Application Discontinuation
- 1999-10-28 IL IL14255799A patent/IL142557A0/xx unknown
- 1999-10-28 RU RU2001114216/15A patent/RU2223782C2/ru not_active IP Right Cessation
- 1999-10-28 KR KR1020017005365A patent/KR20010082272A/ko not_active Application Discontinuation
- 1999-10-28 CN CNB998128287A patent/CN1183961C/zh not_active Expired - Fee Related
- 1999-10-28 BR BR9914834-0A patent/BR9914834A/pt not_active IP Right Cessation
- 1999-10-28 CA CA002347107A patent/CA2347107A1/en not_active Abandoned
- 1999-10-28 HU HU0104126A patent/HUP0104126A3/hu unknown
-
2001
- 2001-04-12 US US09/834,008 patent/US6919312B2/en not_active Expired - Fee Related
- 2001-04-23 ZA ZA200103296A patent/ZA200103296B/en unknown
- 2001-04-27 NO NO20012106A patent/NO20012106L/no unknown
-
2002
- 2002-06-05 HK HK02104289.0A patent/HK1042847A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20012106D0 (no) | 2001-04-27 |
| KR20010082272A (ko) | 2001-08-29 |
| TW529954B (en) | 2003-05-01 |
| IL142557A0 (en) | 2002-03-10 |
| HUP0104126A2 (hu) | 2002-03-28 |
| AU6487799A (en) | 2000-05-15 |
| CZ20011378A3 (cs) | 2001-10-17 |
| BR9914834A (pt) | 2001-08-14 |
| JP3860415B2 (ja) | 2006-12-20 |
| RU2223782C2 (ru) | 2004-02-20 |
| CA2347107A1 (en) | 2000-05-04 |
| EP1127578A1 (en) | 2001-08-29 |
| TR200101146T2 (tr) | 2001-09-21 |
| CN1183961C (zh) | 2005-01-12 |
| US6919312B2 (en) | 2005-07-19 |
| ZA200103296B (en) | 2001-10-25 |
| EP1127578A4 (en) | 2004-12-15 |
| PL347559A1 (en) | 2002-04-08 |
| NZ511506A (en) | 2004-02-27 |
| MXPA01004225A (es) | 2002-06-04 |
| HK1042847A1 (zh) | 2002-08-30 |
| AU755422B2 (en) | 2002-12-12 |
| US20010031725A1 (en) | 2001-10-18 |
| CN1325310A (zh) | 2001-12-05 |
| NO20012106L (no) | 2001-06-21 |
| WO2000024416A1 (fr) | 2000-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0104255A3 (en) | An pharmaceutical composition suitable for inhalation | |
| GB2341960B (en) | Medical calculator | |
| AU3486100A (en) | Bi-fed offset pitch bone screw | |
| IL141821A0 (en) | Inhaler | |
| GB9817118D0 (en) | Pharmaceutical compounds | |
| GB9817623D0 (en) | Pharmaceutical compounds | |
| GB9920785D0 (en) | Bone splint | |
| PT1466615E (pt) | Composição farmacêutica | |
| GB9810886D0 (en) | Pharmaceutical compounds | |
| PL343769A1 (en) | Pharmaceutical composition | |
| GB9818591D0 (en) | Pharmaceutical composition | |
| HUP0104126A3 (en) | Remedies for bone metabolic errors | |
| HUP0102380A3 (en) | Remedies for hypercalcemic crisis | |
| HK1047237A1 (zh) | 糖尿病治療劑 | |
| GB9823847D0 (en) | Pharmaceutical compounds | |
| HK1044117B (zh) | 藥物組合物 | |
| GB9823845D0 (en) | Pharmaceutical compounds | |
| EP1157697A4 (en) | REMEDIES FOR HYPERAMMONIA | |
| GB9817197D0 (en) | Pharmaceutical compounds | |
| AU8386098A (en) | Orthopedic supports | |
| GB9827865D0 (en) | Medicament | |
| HU9800078D0 (en) | Pharmaceutical composition | |
| GB9800784D0 (en) | Medical plasters for all | |
| ZA986040B (en) | Orthopedic supports | |
| TW375027U (en) | Diaper for the patient |